7 Results for "

hepatobiliary diseases

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "hepatobiliary diseases" in MCE Product Catalog:

Cat. No.: HY-W403933
CAS No.: 2458-08-4
12-Ketochenodeoxycholic acid is an anomalous bile acid and Chenodeoxycholic acid (HY-76847) precursor. 12-Ketochenodeoxycholic acid can be used for the research of hepatobiliary diseases .
loading...
    loading...
Cat. No.: HY-N9945
CAS No.: 14772-95-3
3-Oxo-7-hydroxychol-4-enoic acid is an endogenous metabolite. 3-Oxo-7-hydroxychol-4-enoic acid may be an important indicator of a poor prognosis in hepatobiliary disease .
loading...
    loading...
Cat. No.: HY-N9944
CAS No.: 88179-71-9
3-Oxo-4,6-choladien-24-oic acid is an endogenous metabolite. 3-Oxo-4,6-choladien-24-oic acid exsists in the urine of patients with hepatobiliary disease .
loading...
    loading...
Cat. No.: HY-W403933R
CAS No.: 2458-08-4
12-Ketochenodeoxycholic acid (Standard) is an analytical standard of 12-Ketochenodeoxycholic acid (HY-W403933). This product is intended for research and analytical applications. 12-Ketochenodeoxycholic acid is an anomalous bile acid and Chenodeoxycholic acid (HY-76847) precursor. 12-Ketochenodeoxycholic acid can be used for the research of hepatobiliary diseases .
loading...
    loading...
Cat. No.: HY-N9944R
CAS No.: 88179-71-9
3-Oxo-4,6-choladien-24-oic acid (Standard) is the analytical standard of 3-Oxo-4,6-choladien-24-oic acid. This product is intended for research and analytical applications. 3-Oxo-4,6-choladien-24-oic acid is an endogenous metabolite. 3-Oxo-4,6-choladien-24-oic acid exsists in the urine of patients with hepatobiliary disease[1].
loading...
    loading...
Cat. No.: HY-N9945R
CAS No.: 14772-95-3
3-Oxo-7-hydroxychol-4-enoic acid is an endogenous metabolite. 3-Oxo-7-hydroxychol-4-enoic acid may be an important indicator of a poor prognosis in hepatobiliary disease .
loading...
    loading...
Cat. No.: HY-183565
CAS No.: 1417997-91-1
Target:  

HDAC

Research Areas:  

Neurological Disease

HYF031 is a selective, blood-brain barrier-permeable HDAC8 inhibitor with an IC50 of 5.7 nM, and exhibits extremely low activity against most other HDAC subtypes. HYF031 is applicable for HDAC8 imaging studies .
loading...
    loading...